DE2953954A1 - - Google Patents

Info

Publication number
DE2953954A1
DE2953954A1 DE19792953954 DE2953954A DE2953954A1 DE 2953954 A1 DE2953954 A1 DE 2953954A1 DE 19792953954 DE19792953954 DE 19792953954 DE 2953954 A DE2953954 A DE 2953954A DE 2953954 A1 DE2953954 A1 DE 2953954A1
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19792953954
Other languages
German (de)
Other versions
DE2953954C2 (enExample
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DE2953954A1 publication Critical patent/DE2953954A1/de
Application granted granted Critical
Publication of DE2953954C2 publication Critical patent/DE2953954C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
  • Moulding By Coating Moulds (AREA)
  • Dental Preparations (AREA)
DE2953954A 1978-08-21 1979-08-17 Expired DE2953954C2 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/935,199 US4200642A (en) 1978-08-21 1978-08-21 Spiro-oxazolidindiones

Publications (2)

Publication Number Publication Date
DE2953954A1 true DE2953954A1 (enExample) 1982-09-02
DE2953954C2 DE2953954C2 (enExample) 1987-12-03

Family

ID=25466700

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2933441A Expired DE2933441C2 (de) 1978-08-21 1979-08-17 Spiro-[4H-2,3-dihydrobenzopyran(4,5')oxazolidin]-2',4'-dione und solche Verbindungen enthaltende Arzneimittel
DE2953954A Expired DE2953954C2 (enExample) 1978-08-21 1979-08-17

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE2933441A Expired DE2933441C2 (de) 1978-08-21 1979-08-17 Spiro-[4H-2,3-dihydrobenzopyran(4,5')oxazolidin]-2',4'-dione und solche Verbindungen enthaltende Arzneimittel

Country Status (34)

Country Link
US (1) US4200642A (enExample)
JP (4) JPS6011914B2 (enExample)
AR (1) AR225614A1 (enExample)
AT (1) AT366689B (enExample)
AU (1) AU535170B2 (enExample)
BE (1) BE878311A (enExample)
CA (1) CA1121361A (enExample)
CH (1) CH639974A5 (enExample)
CS (1) CS208129B2 (enExample)
DD (1) DD146602A5 (enExample)
DE (2) DE2933441C2 (enExample)
DK (1) DK258479A (enExample)
EG (1) EG14639A (enExample)
ES (1) ES483511A1 (enExample)
FI (1) FI65255C (enExample)
FR (3) FR2442851A1 (enExample)
GB (2) GB2028318B (enExample)
GR (1) GR71913B (enExample)
HU (1) HU179746B (enExample)
IE (1) IE48932B1 (enExample)
IL (1) IL58076A (enExample)
IN (1) IN152416B (enExample)
IT (1) IT1123536B (enExample)
LU (1) LU81613A1 (enExample)
NL (1) NL7906318A (enExample)
NO (1) NO792699L (enExample)
NZ (1) NZ191350A (enExample)
PH (1) PH18091A (enExample)
PL (1) PL130686B1 (enExample)
PT (1) PT70086A (enExample)
SE (1) SE447116B (enExample)
SU (1) SU942597A3 (enExample)
YU (1) YU41488B (enExample)
ZA (1) ZA794379B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329459A (en) * 1980-05-05 1982-05-11 The Upjohn Company Tetrahydrobenzopyran derivatives
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
GB2080803B (en) * 1980-07-28 1984-01-18 Pfizer Hypoglycemic 5-substituted oxazolidine-2,4-diones
ES8400116A1 (es) * 1981-10-13 1983-10-16 Pfizer "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
US4430337A (en) * 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4464380A (en) * 1983-05-25 1984-08-07 Pfizer Inc. Imidazolidinedione derivatives
US4533667A (en) * 1983-05-25 1985-08-06 Pfizer Inc. Imidazolidinedione derivatives
DK277484A (da) * 1983-06-23 1984-12-24 Hoffmann La Roche Thiazolidinderivater
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
DE3522791C1 (en) * 1985-06-26 1987-01-02 Ferroplast Gmbh Positioning wall for lagging a cavity to be filled with a hardenable material in mining or tunnelling
US4853410A (en) * 1986-01-17 1989-08-01 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US5102886A (en) * 1990-10-12 1992-04-07 American Home Products Corporation 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
FR2707981B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2725206B1 (fr) * 1994-09-29 1996-12-06 Roussel Uclaf Nouvelles imidazolidines substituees par un heterocycle, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
US6380191B1 (en) 1999-06-18 2002-04-30 Merck & Co. Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
EP1194146B1 (en) 1999-06-18 2006-07-19 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
ITPI20060083A1 (it) * 2006-07-11 2008-01-12 Univ Pisa Derivati 2,2-dimetilcromanici 4-spiro-eterocicilici azotati (a 5 e 6 termini) n-sostituiti quali cardio-protettori nei confronti dell'insulto ischemico
USD775790S1 (en) * 2015-11-18 2017-01-10 Ginger Damon Motorcycle jacket
US11612525B2 (en) 2017-12-21 2023-03-28 Essity Hygiene And Health Aktiebolag Absorbent article and method for manufacturing an absorbent article
CN111465377A (zh) 2017-12-21 2020-07-28 易希提卫生与保健公司 包括强壮的通道密封结合的吸收性物品
CN116850183B (zh) * 2021-04-30 2026-05-26 远大医药（中国）有限公司 用于治疗近视的方法和药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204232B (de) * 1959-07-16 1965-11-04 Ncr Co Verfahren zur Herstellung von Derivaten von 3-Alkyl-3'-methyl-spiro[benzoxazolin-2, 2'-(2'H-1'-benzopyran)]
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Chem. Abstr. 88 (1978), Ref. 37 454 *
Chem. Abstr. 89 (1978), Ref. 109 942 *
Chem. Ber. 106 (1973), S. 587-593 *
J. C. S. Chem. Commun. (1973), 55-56 *
J. f. Prakt. Chem. 315 (1973), S. 367-374 *
J. Org. Chem. 39 (1974), S. 914-917 *

Also Published As

Publication number Publication date
NL7906318A (nl) 1980-02-25
EG14639A (en) 1985-03-31
AU5009279A (en) 1980-02-28
CA1121361A (en) 1982-04-06
JPS55129279A (en) 1980-10-06
YU41488B (en) 1987-08-31
FI65255C (fi) 1984-04-10
SE447116B (sv) 1986-10-27
DE2933441C2 (de) 1987-04-23
LU81613A1 (fr) 1980-04-21
AU535170B2 (en) 1984-03-08
US4200642A (en) 1980-04-29
GB2028318B (en) 1982-08-04
IL58076A (en) 1982-07-30
JPS6011915B2 (ja) 1985-03-28
IT7925182A0 (it) 1979-08-20
ATA560579A (de) 1981-09-15
JPS5943954B2 (ja) 1984-10-25
HU179746B (en) 1982-12-28
CH639974A5 (fr) 1983-12-15
DE2953954C2 (enExample) 1987-12-03
FI792567A7 (fi) 1980-02-22
IE791592L (en) 1980-02-21
IN152416B (enExample) 1984-01-07
JPS5946517B2 (ja) 1984-11-13
PT70086A (en) 1979-09-01
FR2440949A1 (fr) 1980-06-06
AR225614A1 (es) 1982-04-15
DD146602A5 (de) 1981-02-18
SU942597A3 (ru) 1982-07-07
JPS55129280A (en) 1980-10-06
FR2440950A1 (fr) 1980-06-06
CS208129B2 (en) 1981-08-31
JPS55129288A (en) 1980-10-06
YU199979A (en) 1983-06-30
FR2440950B1 (enExample) 1981-06-12
ZA794379B (en) 1980-08-27
NZ191350A (en) 1984-04-27
IT1123536B (it) 1986-04-30
FR2440949B1 (enExample) 1981-06-12
IL58076A0 (en) 1979-12-30
FR2442851A1 (fr) 1980-06-27
GB2033904A (en) 1980-05-29
SE7906949L (sv) 1980-02-22
GB2028318A (en) 1980-03-05
JPS5528996A (en) 1980-02-29
JPS6011914B2 (ja) 1985-03-28
FR2442851B1 (enExample) 1983-06-17
PL217881A1 (enExample) 1981-01-02
GR71913B (enExample) 1983-08-16
PL130686B1 (en) 1984-08-31
DK258479A (da) 1980-02-22
NO792699L (no) 1980-02-22
BE878311A (fr) 1980-02-20
PH18091A (en) 1985-03-20
GB2033904B (en) 1982-08-04
DE2933441A1 (de) 1980-02-28
FI65255B (fi) 1983-12-30
AT366689B (de) 1982-04-26
ES483511A1 (es) 1980-09-01
IE48932B1 (en) 1985-06-26

Similar Documents

Publication Publication Date Title
FR2415673B1 (enExample)
FR2440950B1 (enExample)
FR2417057B1 (enExample)
FR2415249B1 (enExample)
FR2414988B1 (enExample)
AU3898778A (enExample)
FR2414405B1 (enExample)
FR2414264B2 (enExample)
DK141736C (enExample)
FR2416282B1 (enExample)
AU3892778A (enExample)
AU73950S (enExample)
BG25955A1 (enExample)
BG26013A1 (enExample)
BG26225A1 (enExample)
BG25836A1 (enExample)
BG26014A1 (enExample)
BG26009A1 (enExample)
BG25940A1 (enExample)
BG26006A1 (enExample)
BG25858A1 (enExample)
BG25898A1 (enExample)
BG25874A1 (enExample)
BG25921A1 (enExample)
BG25956A1 (enExample)

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 2933441

8110 Request for examination paragraph 44
8126 Change of the secondary classification

Free format text: C07D313/08 C07F 7/18

8128 New person/name/address of the agent

Representative=s name: LEDERER, F., DIPL.-CHEM. DR., PAT.-ANW., 8000 MUEN

AC Divided out of

Ref country code: DE

Ref document number: 2933441

Format of ref document f/p: P

AC Divided out of

Ref country code: DE

Ref document number: 2933441

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee